Studies have found that increased oxidative stress in RA patients leads to reduced bioavailability of nitric oxide (NO) and decreased levels of cyclic guanosine monophosphate (cGMP) and protein kinase G (PKG) in the myocardium, further promoting cardiac hypertrophy and increased resting tension [18, 19]. The gene discussed is PRKG1; the disease is cardiac hypertrophy.